Atlas builds a behind-the-ear multi-modal EEG nanosensor wearable that decodes brain signals in real time to track mental clarity, focus, and acuity. The companion app provides instant feedback on how daily behaviors affect cognitive performance. Co-founded by neuroscientists Ana Montero and André Marques-Smith, the company emerged from stealth with $14 million in funding and plans to launch in 2026. It operates as part of Occam Bio Ltd and is backed by investors including Refactor Capital.